Cargando…
In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
AIMS: The severe acute respiratory syndrome coronavirus 2, better known as COVID-19 has become the current health concern to the entire world. Initially appeared in Wuhan, China around December 2019, it had spread to almost 187 countries due to its high contagious nature. Precautionary measures rema...
Autores principales: | Shah, Bhumi, Modi, Palmi, Sagar, Sneha R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194845/ https://www.ncbi.nlm.nih.gov/pubmed/32278693 http://dx.doi.org/10.1016/j.lfs.2020.117652 |
Ejemplares similares
-
Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023) -
In silico drug repurposing in COVID-19: A network-based analysis
por: Sibilio, Pasquale, et al.
Publicado: (2021) -
Corrigendum: Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023) -
Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach
por: Sahu, Anshuman, et al.
Publicado: (2023) -
Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
por: Diao, James A., et al.
Publicado: (2022)